New York Hedge Fund Seeks Sale Of Microchip Company

Mar 24 2008 | 10:59am ET

Obrem Capital Management thinks a circuit has burned out at microchip manufacturer Micrel. And it has the solution: Sell.

The New York hedge fund earlier this month sent a letter to Micrel management, chastising it for “a poorly-developed outsourcing strategy” and “bloated cost structure.” The firm, which owns 9.6% of San Jose, Calif.-based Micrel, has asked to meet with the company’s board of directors, but it has already reached its conclusion: “the Board would maximize value for Micrel’s shareholders by selling the company to a strategic buyer,” namely a larger semiconductor company.

According to Obrem—which demands at a minimum that the company set up a special committee to investigate strategic alternatives—current management will be unable to boost sales or improve Micrel’s cost structure.


In Depth

Royalties: The Alternative Assets of the Music Industry

Jul 8 2016 | 7:01pm ET

Recent market volatility has investors seeking greater insight into alternative...

Lifestyle

Moore Capital PM Fired After Raucous Hamptons Party

Jul 7 2016 | 10:47pm ET

A portfolio manager for Louis Bacon’s $15 billion hedge fund Moore Capital Management...

Guest Contributor

MPI: Like Stellar Returns? Better Understand the Risks First

Jul 22 2016 | 8:44pm ET

When the press reports extraordinarily strong relative or risk-adjusted returns...